Investigating Pseudomonas aeruginosa physiology and the impact of pathoadaptive mutations, in a polymicrobial airway environment

BBSRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 29, 2027
Response Due
Active
Status

Opportunity Overview

BBSRC strategic theme: Bioscience for an integrated understanding of health

The airways of people with cystic fibrosis (CF) are often colonised by a diverse "zoo" of microbes, especially during their early and teenage years. These polymicrobial communities have historically proven difficult to recapitulate in the laboratory environment, so, until now, most research has involved monoculture of key pathogens such as Pseudomonas aeruginosa. It is becoming increasingly clear, however, that pathogens in multi-species systems often behave radically differently than when grown in pure axenic cultures, and, as such, recent years have seen a growing interest in efforts to recapitulate the complex CF microbiota in vitro.

The Welch Lab has developed an in vitro laboratory model that accurately captures the long-term stability of the polymicrobial community present in CF airways. In brief, the setup consists of a continuous flow bioreactor in which the rate of fluid - specifically, artificial sputum media - replacement reflects that seen in the airways. The current model incorporates three major CF-associated pathogens: P. aeruginosa, Staphylococcus aureus, and Candida albicans. This system has opened new possibilities for interrogation of the biology of CF-associated polymicrobial airway infections, and has already yielded some intriguing new insights.

In this project, I will introduce other common CF-associated pathogens into the in vitro model system, alongside the current three, for example: Haemophilus influenzae, Rothia mucilaginosa, and Streptococcus milleri. I will then use this "improved" model system to examine the impacts of the presence of P. aeruginosa mutants in the polymicrobial community. The P. aeruginosa population observed in CF airway infections is not homogenous, with mutant variants frequently observed. Loss-of-function mutations in certain genes are commonly over-represented in CF, indicating they may confer increased fitness in this environment;...

This is one of 2,051 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyBBSRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2023
Procurement stageActive solicitation
Response dueSeptember 29, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedSeptember 21, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Precision-targeting of pathogens using bacteriophage and antimicrobial peptides
PAML 5: A friendly and powerful bioinformatics resource for phylogenomics
Something in the air - investigating the impact of air pollution on neurodevelopment in the zebrafish model.
Structural bioinformatics and chemogenomics approaches to navigate GPCR ligand interaction space
Assessing the threat of antimicrobial resistance: A framework to support decision-making to ensure resilient aquaculture supplies
Developmental mechanisms of air space morphogenesis in plant leaves
Modulation of a neuromodulator: Insulin sensing in the basal forebrain
Novel multi excitation Raman ME Raman technologies for clinical identification of respiratory biofilms in ventilator associated pneumonia VAP

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.